Skip to main content
MEHA
NASDAQ Life Sciences

Nasdaq to Delist Functional Brands (MEHA) Stock; Trading Suspension Imminent

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Food & Beverage Stocks · Consumer
Sentiment info
Negative
Importance info
10
Price
$0.042
Mkt Cap
$1.77M
52W Low
$0.039
52W High
$8
52W Position info
7.2% above low
Off High info
99% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

MEHA is trading near its 52-week low of $0.039 (7.2% above the low) on light trading volume (0.1× avg).

Summary

Functional Brands Inc. faces immediate delisting from Nasdaq, with trading suspended on June 16, 2026, due to its failure to meet minimum bid price requirements.


Key Events · Corporate Governance and Compliance · MEHA

  • Nasdaq Delisting Determination

    Functional Brands Inc. received a Staff Determination from Nasdaq on June 9, 2026, to delist its common stock.

  • Imminent Trading Suspension

    Trading of MEHA common stock will be suspended at the opening of business on June 16, 2026, due to the stock trading below $0.10 for ten consecutive days.

  • Appeal Will Not Stay Suspension

    The company may appeal the delisting decision, but a request for a hearing will not prevent the immediate trading suspension.

  • Failure to Meet Listing Rules

    The delisting is a result of the company's failure to comply with Nasdaq's Low Priced Stocks Rule, specifically the $0.10 minimum bid price requirement.


Analysis · MEHA · Life Sciences

Functional Brands Inc. has received a Staff Determination from Nasdaq to delist its common stock, effective with a trading suspension on June 16, 2026. This action follows the company's failure to maintain a minimum bid price of $0.10 for ten consecutive trading days, a critical violation of Nasdaq's Low Priced Stocks Rule. While the company can appeal, the appeal will not prevent the immediate trading suspension, significantly impacting liquidity and investor access. This event marks a severe setback for the company, which had previously sought shareholder approval for a reverse stock split to avoid delisting.

At the time of this filing, MEHA was trading at $0.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $0.04 to $8.00. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MEHA - Latest Insights

MEHA
Jul 02, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0043
Real-time Price: $0.0043 info
Change: $0 (0%) info
Market Cap: $181.488K info
MEHA
Jun 30, 2026, 6:46 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $0.0052
Real-time Price: $0.0043 info
Change: -$0.0009 (-17%) info
Market Cap: $181.488K info
MEHA
Jun 15, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
10
Price at Filing: $0.038
Real-time Price: $0.0043 info
Change: -$0.0337 (-89%) info
Market Cap: $181.488K info
MEHA
Jun 05, 2026, 2:29 PM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.0722
Real-time Price: $0.0043 info
Change: -$0.0679 (-94%) info
Market Cap: $181.488K info
MEHA
Jun 04, 2026, 9:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.0682
Real-time Price: $0.0043 info
Change: -$0.0639 (-94%) info
Market Cap: $181.488K info